FOX Health

GLP-1 medications like Ozempic show promise for multiple health conditions, as experts explore microdosing benefits for blood sugar control and longevity.

Cardiothoracic surgeon Dr. Jeremy London discusses the 80/20 diet approach for heart health, emphasizing whole foods 80% of the time while limiting alcohol and processed foods.

A new study reveals that sucralose may reduce cancer treatment effectiveness, but supplementation could counteract the artificial sweetener’s negative effects.

A new study shows that LSD reduced anxiety symptoms in adults with generalized anxiety disorder, with 100-microgram doses proving most effective in a clinical trial.

Researchers discovered Human Pegivirus in brain tissue from five of ten Parkinson’s patients, suggesting the virus may play a role in the neurodegenerative disease.

Scientists have created a pre-clinical weight loss drug combining GLP-1, GIP, glucagon and peptide YY hormones to match bariatric surgery effectiveness.

Researchers suggest intense marathon training may cause gut stress leading to colon adenomas, with 41% of studied runners having at least one polyp.

Research identifies five food additive categories including flavors, sweeteners and coloring agents that may significantly increase all-cause mortality risk.

Orthopedist Dr. Ran Schwarzkopf of NYU explains how knee pain affects more young people in their 30s and 40s due to obesity and high-intensity sports.

A new study from Beth Israel Deaconess Medical Center in Boston finds that using smartphones in the bathroom increases hemorrhoid risk by nearly 50%.